A detailed history of Tower Research Capital LLC (Trc) transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 803 shares of AMRX stock, worth $6,255. This represents 0.0% of its overall portfolio holdings.

Number of Shares
803
Previous 27,589 97.09%
Holding current value
$6,255
Previous $175,000 96.57%
% of portfolio
0.0%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$6.42 - $8.83 $171,966 - $236,520
-26,786 Reduced 97.09%
803 $6,000
Q2 2024

Aug 13, 2024

BUY
$5.36 - $7.11 $132,236 - $175,410
24,671 Added 845.48%
27,589 $175,000
Q1 2024

May 15, 2024

SELL
$5.24 - $6.34 $165,143 - $199,811
-31,516 Reduced 91.53%
2,918 $17,000
Q4 2023

Feb 13, 2024

BUY
$3.36 - $6.21 $100,044 - $184,902
29,775 Added 639.09%
34,434 $209,000
Q3 2023

Nov 14, 2023

SELL
$2.76 - $4.59 $17,956 - $29,862
-6,506 Reduced 58.27%
4,659 $19,000
Q2 2023

Aug 14, 2023

BUY
$1.33 - $3.1 $8,098 - $18,875
6,089 Added 119.96%
11,165 $34,000
Q1 2023

May 09, 2023

SELL
$1.27 - $2.7 $4,271 - $9,080
-3,363 Reduced 39.85%
5,076 $7,000
Q4 2022

Feb 10, 2023

BUY
$1.96 - $2.61 $2,110 - $2,810
1,077 Added 14.63%
8,439 $17,000
Q3 2022

Nov 10, 2022

BUY
$2.02 - $3.62 $977 - $1,752
484 Added 7.04%
7,362 $15,000
Q2 2022

Aug 15, 2022

BUY
$3.01 - $4.46 $13,632 - $20,199
4,529 Added 192.81%
6,878 $22,000
Q1 2022

May 12, 2022

SELL
$3.9 - $4.89 $1,072 - $1,344
-275 Reduced 10.48%
2,349 $9,000
Q4 2021

Feb 14, 2022

SELL
$3.95 - $5.85 $29,589 - $43,822
-7,491 Reduced 74.06%
2,624 $13,000
Q3 2021

Nov 15, 2021

SELL
$4.31 - $5.64 $21,670 - $28,357
-5,028 Reduced 33.2%
10,115 $54,000
Q2 2021

Aug 16, 2021

BUY
$5.12 - $6.82 $26,542 - $35,354
5,184 Added 52.05%
15,143 $78,000
Q1 2021

May 17, 2021

SELL
$4.74 - $7.38 $155,050 - $241,407
-32,711 Reduced 76.66%
9,959 $67,000
Q4 2020

Feb 16, 2021

SELL
$3.95 - $5.42 $381,814 - $523,908
-96,662 Reduced 69.38%
42,670 $195,000
Q3 2020

Nov 16, 2020

BUY
$3.54 - $5.27 $368,878 - $549,149
104,203 Added 296.63%
139,332 $540,000
Q2 2020

Aug 13, 2020

BUY
$2.87 - $5.46 $100,820 - $191,804
35,129 New
35,129 $167,000
Q4 2019

Feb 07, 2020

SELL
$2.65 - $5.56 $14,344 - $30,096
-5,413 Closed
0 $0
Q3 2019

Nov 05, 2019

SELL
$2.29 - $7.1 $5,388 - $16,706
-2,353 Reduced 30.3%
5,413 $16,000
Q2 2019

Aug 13, 2019

BUY
$6.44 - $14.29 $44,397 - $98,515
6,894 Added 790.6%
7,766 $56,000
Q1 2019

May 14, 2019

SELL
$11.87 - $14.84 $9,828 - $12,287
-828 Reduced 48.71%
872 $12,000
Q4 2018

Feb 14, 2019

BUY
$13.09 - $21.49 $22,253 - $36,533
1,700 New
1,700 $23,000

Others Institutions Holding AMRX

About Amneal Pharmaceuticals, Inc.


  • Ticker AMRX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 151,408,992
  • Market Cap $1.18B
  • Description
  • Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...
More about AMRX
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.